Skip to main content
TipRanks
Go Ultimate75% OFF

Guardian Pharmacy Services, Inc. Class A (GRDN) Stock Price & Analysis

34 Followers

GRDN Stock Chart & Stats

$50.33$0.90(1.82%)
At close: 4:00 PM EST
$40$45$50Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
$49.20 - $50.80
52-Week Range
$26.34 - $50.80
Previous Close
$49.43
Volume
N/A
Average Volume (3M)
481.42K
Market Cap
$3.19B
Enterprise Value
$2.53B
Total Cash (Recent Filing)
$119.66M
Total Debt (Recent Filing)
$35.59M
Price to Earnings (P/E)
42.5
Beta
0.45
Next Earnings
Mar 31, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Resident And Prescription Volume Growth

Growth in residents and prescriptions indicates increasing utilization of Guardian’s pharmacy platform within its target care settings. Higher recurring volume can deepen facility relationships, improve operating leverage, and support durable expansion as the company adds customers and locations.

Debt-free Balance Sheet And Cash Generation

A debt-free balance sheet and substantial cash position provide financial flexibility to fund acquisitions, greenfield pharmacies, and operating investment without relying on external financing. This strengthens resilience and allows management to pursue growth while avoiding direct exposure to borrowing costs.

Raised Outlook And Expansion Runway

Raised revenue and EBITDA guidance reflects stronger operating performance, improved reimbursement, and market expansion initiatives. The outlook also excludes additional acquisitions beyond those completed, suggesting the existing platform and identified expansion efforts can support continued earnings growth.

Bears Say

IRA-related Pricing Pressure

IRA-related drug price reductions are already weighing on reported revenue and create an ongoing reimbursement risk for the business. Even if underlying prescription demand remains healthy, policy-driven pricing changes can limit top-line growth and complicate forecasting across future periods.

Expansion Investments Weigh On Margins

Guardian’s growth strategy requires continued investment in acquisitions and new pharmacies before those cohorts mature. This creates recurring margin dilution and earnings variability, meaning strong volume growth may not translate immediately into proportional profitability while expansion remains active.

Elevated Operating Costs

The delivery-intensive model remains exposed to elevated fuel and broader operating costs. Persistent expense pressure can absorb part of the benefit from reimbursement improvements and volume growth, making margin preservation dependent on purchasing, route, and operating efficiencies.

Guardian Pharmacy Services, Inc. Class A News

GRDN FAQ

What was Guardian Pharmacy Services, Inc. Class A’s price range in the past 12 months?
Guardian Pharmacy Services, Inc. Class A lowest stock price was $26.34 and its highest was $50.80 in the past 12 months.
What is Guardian Pharmacy Services, Inc. Class A’s market cap?
Guardian Pharmacy Services, Inc. Class A’s market cap is $3.19B.
When is Guardian Pharmacy Services, Inc. Class A’s upcoming earnings report date?
Guardian Pharmacy Services, Inc. Class A’s next earnings report is estimated for Mar 31, 2027 (not yet confirmed), which is in 132 days.
How were Guardian Pharmacy Services, Inc. Class A’s earnings last quarter?
Guardian Pharmacy Services, Inc. Class A released its earnings results on Nov 05, 2026. The company reported $0.33 earnings per share for the quarter, beating the consensus estimate of $0.315 by $0.015.
Is Guardian Pharmacy Services, Inc. Class A overvalued?
According to Wall Street analysts Guardian Pharmacy Services, Inc. Class A’s price is currently Undervalued.
Does Guardian Pharmacy Services, Inc. Class A pay dividends?
Guardian Pharmacy Services, Inc. Class A does not currently pay dividends.
What is Guardian Pharmacy Services, Inc. Class A’s EPS estimate?
Guardian Pharmacy Services, Inc. Class A’s EPS estimate is 0.45.
How many shares outstanding does Guardian Pharmacy Services, Inc. Class A have?
Guardian Pharmacy Services, Inc. Class A has 63,320,300 shares outstanding.
What happened to Guardian Pharmacy Services, Inc. Class A’s price movement after its last earnings report?
Guardian Pharmacy Services, Inc. Class A reported an EPS of $0.33 in its last earnings report, beating expectations of $0.315. Following the earnings report the stock price went up 6.321%.
Which hedge fund is a major shareholder of Guardian Pharmacy Services, Inc. Class A?
Hedge funds hold Guardian Pharmacy Services, Inc. Class A shares: the largest hedge-fund position in Guardian Pharmacy Services, Inc. Class A is 72,325,231 shares, and hedge funds decreased their holdings by 260.7K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology